The growing CBD market, cannabis stocks, CBD and athletes, and cannabinoid pharmaceuticals among the news from our portfolio of companies this week.
Medical Marijuana, Inc. and our family of companies continued to make news this week as we work to innovate the CBD industry, educate on the benefits of CBD and promote its use, pursue cannabinoid-based pharmaceuticals, and much more. Keep reading for our biggest headlines from the past week.
Major Business Media Lists MJNA as CBD Stock to Buy
Medical Marijuana, Inc. was featured as a top 4 CBD stock in recent coverage by Fox Business, Motley Fool, and Nasdaq.com in coverage this week. Investors are getting excited about the predicted growth the CBD market is expected to experience over the next four years.
According to an article on the Motley Fool, “There’s an even hotter industry that’s budding from within the marijuana movement: cannabidiol (CBD). CBD is the non-psychoactive cannabinoid best known for its perceived medical benefits, and since it won’t get a user high, it’s become an intriguing means of luring in new consumers who’ve never tried a cannabis-related product before.”
The article continues, “According to a report from the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022, which works out to a compound annual growth rate of 147%, for those of you keeping score at home.”
With so much anticipated growth surrounding the CBD market, many investors are looking to get involved in the CBD industry. Medical Marijuana, Inc. was the first U.S. company entirely within the cannabis space to be publicly traded. Medical Marijuana, Inc. is also the first company to create and distribute hemp-derived CBD products.
“Like its peers, Medical Marijuana has seen its top line moving in the right direction. Third-quarter revenue, reported back in November, was slightly over $16.8 million, representing a 116% year-over-year increase… In the third quarter, the company generated an operating profit, after expenses, of $0.6 million,” an article on Fox Business reads.
Interested in investing in Medical Marijuana, Inc.? Learn more here.
Forbes Explores Demand for CBD Supplement Market in the U.S.
The CBD industry in America was under Forbes’ lense when the business news outlet looked at the current state CBD in the U.S., regulatory uncertainties around CBD products, and the outcry for access to these products by U.S. consumers.
Following announcements by both CVS and Walgreens revealing their intention to carry CBD products on their shelves in the near future and the FDA’s response, Forbes published an article investigating CBD’s projected growth and potential hurdles to this growth.
CEO of Kannaway Blake Schroeder was interviewed by Forbes for the article. “For Schroeder, who supports CBD being regulated as a dietary supplement, the main difference comes down to access. “If you can buy something online or in a store without having to see your doctor first, people are going to have better access to the product,” Schroeder told me.”
“I think that you’re going to see more governments the non-psychoactive components as good for people. It will cut down on medical costs and reliance on certain prescriptions. There’s a lot of opportunities out there, but there’s a lot of education that needs to be done as well,” Schroeder continued.
The article also looked to our southern border with an interview with Raul Elizalde, president of HempMeds® Latin America. Following his fight against the Mexican government for access to CBD for his daughter, Raul was invited to speak before World Health Organization officials on the status of CBD. The article reads, “Elizalde supports broader access to the medicinal properties and effects of CBD by considering it a health supplement, as well as a clinically-tested drug.”
As A Company of Firsts®, the Medical Marijuana, Inc. family of companies continues to innovate the CBD industry and advocate for access to CBD around the world. You can learn more about our achievements here.
Benzinga Covers New AXIM Biotechnologies Patent
Medical Marijuana, Inc. investment AXIM® Biotechnologies was featured on Benzinga recently announcing that the company had been approved for a patent for its cannabinoid cream.
According to the article, the company was issued a “Notice of Allowance for a patent from the U.S. Patent and Trademark Office for a topical cream containing cannabinoids for the treatment of atopic dermatitis (eczema).”
Formulated with the cannabinoids CBD and CBG, AXIM®’s topical cream was created by the company to be a non-prescription treatment for the effects of atopic dermatitis. “With this product, AXIM expects to enter an atopic dermatitis market that is valued at $5 billion,” the article reads.
Then AXIM® was in the news again this week when it announced that it has entered an agreement to begin clinical studies on a pair of potential new drugs under its portfolio of intellectual properties.
Both products are chewing gums containing cannabinoids and utilize the company’s patented chewing gum delivery mechanism. CanChew® Rx is formulated with cannabidiol (CBD); MedChew® with Dronabinol makes use of synthetic THC.
This news was covered by the Candid Chronicle.
HempMeds® Brasil Hosts Educational Event
Medical Marijuana, Inc. subsidiary HempMeds® Brasil has been supporting CBD access in Latin America with a series of educational events aimed at helping doctors, politicians, and patients better understand the advantages CBD provides.
“The cannabis industry is taking off in Latin America more than we could have ever expected,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus says in an article posted on PotNetwork. “That said, there are still many misconceptions about CBD, and our mission is to help people become more educated about what it is and its potential health benefits.”
You can learn more about HempMeds® Brasil here.
Kannaway Sports Partner and NFL Star Christian Okoye Talks CBD
Former NFL running back Christian Okoye sat down with USports.org to discuss his daily fitness routine, the importance of staying active, and how he integrates CBD products from Kannaway into his routine. You can view the interview segment here.
Okoye has partnered with the company as part of their Kannaway Sports initiative. The goal of Kannaway Sports is to promote the benefits of CBD use among athletes of all levels through the publication of testimonials from its team of athletes, including former NFL stars, Gold Medalist Olympians, and more.
You can learn more about Kannaway Sports here.
HempMeds® Recipe Featured on Mom and More
A recipe from the HempMeds® website showing consumers how to make CBD-infused butter was listed in an article on Mom and More “4 CBD Infused Recipes to Check Out”. The benefits of CBD-infused butter include the ability to add CBD to a wide range of foods.
“There’s nothing as good as the classic CBD infused butter. It’s one of the most versatile options because you can use it to bake any of your favorite baked goods, from cherry pies to carrot cakes,” the article reads.